Panagora Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Panagora Asset Management’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.13M	Buy	89,599 +22,609	+34%	+$303K	﹤0.01%	691
2025 Q4	$1.06M	Buy	+66,990	New	+$851K	﹤0.01%	702
2020 Q2	–	Sell	-1,114	Closed	-$57K	–	2587
2020 Q1	$57K	Buy	+1,114	New	+$59.4K	﹤0.01%	1853
2018 Q2	–	Sell	-1,458	Closed	-$118K	–	2382
2018 Q1	$118K	Buy	+1,458	New	+$112K	﹤0.01%	1815
2015 Q4	–	Sell	-648	Closed	-$23K	–	2315
2015 Q3	$23K	Buy	648 +39	+6%	+$1.68K	﹤0.01%	2118
2015 Q2	$27K	Buy	+609	New	+$23.7K	﹤0.01%	2258
2015 Q1	–	Sell	-11,613	Closed	-$591K	–	2344
2014 Q4	$591K	Buy	11,613 +9,545	+462%	+$427K	﹤0.01%	1219
2014 Q3	$82K	Sell	2,068 -160	-7%	-$6.38K	﹤0.01%	1913
2014 Q2	$96K	Sell	2,228 -297	-12%	-$11.3K	﹤0.01%	1943
2014 Q1	$101K	Buy	+2,525	New	+$91.7K	﹤0.01%	1929
2013 Q4	–	Sell	-13,546	Closed	-$310K	–	2189
2013 Q3	$310K	Sell	13,546 -9,426	-41%	-$180K	﹤0.01%	1497
2013 Q2	$407K	Buy	+22,972	New	+$448K	﹤0.01%	1386

Other funds holding ENTA

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SSC

Spruce Street Capital New York $416M AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Panagora Asset Management's ENTA Position: Q1 2026 in Review

Panagora Asset Management increased its Enanta Pharmaceuticals (ENTA) stake by 34% in Q1 2026, buying an estimated $303K and bringing the position to 89,599 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #691.

Panagora Asset Management first reported a position in ENTA in Q2 2013 and has held it in 12 quarters since. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

Panagora Asset Management held 89,599 shares of Enanta Pharmaceuticals worth $1.13M as of Q1 2026.
Panagora Asset Management bought 22,609 Enanta Pharmaceuticals shares in Q1 2026, an estimated $303K.
Enanta Pharmaceuticals made up ﹤0.01% of Panagora Asset Management's portfolio in Q1 2026, its #691 holding.
Panagora Asset Management first reported a position in Enanta Pharmaceuticals in Q2 2013 and has held it in 12 quarters since.
132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.